{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:59:06Z","timestamp":1787169546633,"version":"build-2736575974"},"reference-count":140,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Unanticipated pathogenic risk and emerging transmittable diseases can result from interspecies exchanges of viruses among animals and humans. The emergence of the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causing coronavirus disease-19 (COVID-19) pandemic has recently exemplified this mechanism. Cough, fever, fatigue, headache, sputum production, hemoptysis, dyspnea, diarrhea, and gastrointestinal disorders are the characteristic features of the disease. The most prevalent and serious manifestation of the infection tends to be pneumonia. The new strains of SARS-CoV-2 with more infectivity have been emerging at regular intervals. There is currently no World Health Organization-approved particular drug for COVID-19. Besides, developing novel antivirals would take much time. Thus, repurposing the application of natural products can provide alternatives and can facilitate medication against COVID-19 as well as can slow down the aggressive progression of the disease before the arrival of approved drugs. Probiotics have long been known for their positive effects on the gut microbiome and impact on immune responses. Particularly, their involvement against viral diseases, especially those of the upper and lower respiratory tract, is of current interest for their prospective application against COVID-19. In this review, we comprehensively address the mode of action of probiotics and their possible intervention against coronavirus diseases correlating with their efficacy against viral diseases. In this regard, we explored recently published relevant research and review articles in MEDLINE\/PubMed related to COVID-19 and the effects of probiotics on viral infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tcmj.tcmj_104_21","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T08:23:16Z","timestamp":1633422196000},"page":"148-159","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["The prospects of employing probiotics in combating COVID-19"],"prefix":"10.4103","volume":"34","author":[{"given":"Moutoshi","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurab Kishore","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20240828","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle","volume":"92","author":"Lu","year":"2020","journal-title":"J Med Virol"},{"key":"R3-6-20240828","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/trstmh\/traa025","article-title":"COVID-19: A fast evolving pandemic","volume":"114","author":"Whitworth","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R4-6-20240828","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses-drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"R5-6-20240828","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"key":"R8-6-20240828","doi-asserted-by":"crossref","first-page":"E254","DOI":"10.3390\/v12030254","article-title":"Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies","volume":"12","author":"Ahmed","year":"2020","journal-title":"Viruses"},{"key":"R9-6-20240828","doi-asserted-by":"crossref","first-page":"100127","DOI":"10.1016\/j.onehlt.2020.100127","article-title":"The SARS-CoV-2 outbreak from a one health perspective","volume":"10","author":"Hemida","year":"2020","journal-title":"One Health"},{"key":"R10-6-20240828","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"R11-6-20240828","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"R12-6-20240828","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(21)00370-6","article-title":"SARS-CoV-2 variants and ending the COVID-19 pandemic","volume":"397","author":"Fontanet","year":"2021","journal-title":"Lancet"},{"key":"R13-6-20240828","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41591-021-01397-4","article-title":"SARS-CoV-2 variants of concern are emerging in India","volume":"27","author":"Singh","year":"2021","journal-title":"Nat Med"},{"key":"R14-6-20240828","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0140-6736(20)30567-5","article-title":"How will country-based mitigation measures influence the course of the COVID-19 epidemic?","volume":"395","author":"Anderson","year":"2020","journal-title":"Lancet"},{"key":"R15-6-20240828","doi-asserted-by":"crossref","first-page":"791","DOI":"10.20506\/rst.33.3.2318","article-title":"Antiviral chemotherapy in veterinary medicine: Current applications and perspectives","volume":"33","author":"Dal Pozzo","year":"2014","journal-title":"Rev Sci Tech"},{"key":"R16-6-20240828","doi-asserted-by":"crossref","first-page":"596587","DOI":"10.3389\/fmed.2020.596587","article-title":"The need for antiviral drugs for pandemic coronaviruses from a global health perspective","volume":"7","author":"Villamagna","year":"2020","journal-title":"Front Med (Lausanne"},{"key":"R17-6-20240828","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41591-021-01230-y","article-title":"Looking beyond COVID-19 vaccine phase 3 trials","volume":"27","author":"Kim","year":"2021","journal-title":"Nat Med"},{"key":"R19-6-20240828","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document.The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R20-6-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1348-0421.12210","article-title":"Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model","volume":"59","author":"Kawahara","year":"2015","journal-title":"Microbiol Immunol"},{"key":"R21-6-20240828","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/0884533612440290","article-title":"Probiotics in the intensive care unit","volume":"27","author":"Morrow","year":"2012","journal-title":"Nutr Clin Pract"},{"key":"R22-6-20240828","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/gutjnl-2020-320926","article-title":"Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms","volume":"69","author":"Jin","year":"2020","journal-title":"Gut"},{"key":"R23-6-20240828","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/gutjnl-2020-321013","article-title":"Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection","volume":"69","author":"Lin","year":"2020","journal-title":"Gut"},{"key":"R24-6-20240828","doi-asserted-by":"crossref","first-page":"E757","DOI":"10.3390\/nu12030757","article-title":"Probiotics dietary supplementation for modulating endocrine and fertility microbiota dysbiosis","volume":"12","author":"L\u00f3pez-Moreno","year":"2020","journal-title":"Nutrients"},{"key":"R26-6-20240828","first-page":"3409","article-title":"Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment","volume":"39","author":"Boopathi","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"R27-6-20240828","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"R28-6-20240828","doi-asserted-by":"crossref","first-page":"15511","DOI":"10.1128\/JVI.79.24.15511-15524.2005","article-title":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: Role of ciliated cells in viral spread in the conducting airways of the lungs","volume":"79","author":"Sims","year":"2005","journal-title":"J Virol"},{"key":"R29-6-20240828","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2353\/ajpath.2007.061088","article-title":"Pathology and pathogenesis of Severe Acute Respiratory Syndrome","volume":"170","author":"Gu","year":"2007","journal-title":"Am J Pathol"},{"key":"R30-6-20240828","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1165\/rcmb.2012-0339OC","article-title":"Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus","volume":"48","author":"Qian","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R31-6-20240828","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R32-6-20240828","doi-asserted-by":"crossref","first-page":"2000607","DOI":"10.1183\/13993003.00607-2020","article-title":"Pathogenesis of COVID-19 from a cell biology perspective","volume":"55","author":"Mason","year":"2020","journal-title":"Eur Respir J"},{"key":"R33-6-20240828","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1164\/rccm.2014P7","article-title":"Novel Wuhan (2019-NCoV) coronavirus","volume":"201","author":"Carlos","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R34-6-20240828","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"R35-6-20240828","doi-asserted-by":"crossref","first-page":"563893","DOI":"10.3389\/fmed.2020.563893","article-title":"ACE2 Expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection","volume":"7","author":"Fan","year":"2020","journal-title":"Front Med"},{"key":"R36-6-20240828","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fmicb.2020.01388","article-title":"Intestinal Flora as a potential strategy to fight SARS-CoV-2 infection","volume":"11","author":"He","year":"2020","journal-title":"Front Microbiol"},{"key":"R37-6-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-020-02554-1","article-title":"Probiotics in the prophylaxis of COVID-19: Something is better than nothing","volume":"11","author":"Gohil","year":"2021","journal-title":"3 Biotech"},{"key":"R38-6-20240828","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N Engl J Med"},{"key":"R40-6-20240828","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1517\/13543776.2013.823159","article-title":"Anti-SARS coronavirus agents: A patent review (2008-present)","volume":"23","author":"Kumar","year":"2013","journal-title":"Expert Opin Ther Pat"},{"key":"R41-6-20240828","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5582\/bst.2020.01020","article-title":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)","volume":"14","author":"Lu","year":"2020","journal-title":"Biosci Trends"},{"key":"R42-6-20240828","doi-asserted-by":"crossref","first-page":"104545","DOI":"10.1016\/j.antiviral.2019.104545","article-title":"Antivirals targeting the polymerase complex of influenza viruses","volume":"169","author":"Mifsud","year":"2019","journal-title":"Antiviral Res"},{"key":"R43-6-20240828","doi-asserted-by":"crossref","first-page":"104791","DOI":"10.1016\/j.antiviral.2020.104791","article-title":"Type 1 interferons as a potential treatment against COVID-19","volume":"178","author":"Sallard","year":"2020","journal-title":"Antiviral Res"},{"key":"R44-6-20240828","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"R45-6-20240828","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/cid\/ciz544","article-title":"Ribavirin and interferon therapy for critically ill patients with middle east respiratory syndrome: A multicenter observational study","volume":"70","author":"Arabi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R46-6-20240828","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"R47-6-20240828","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"R48-6-20240828","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S2213-2600(20)30172-7","article-title":"Hydroxychloroquine in the management of critically ill patients with COVID-19: The need for an evidence base","volume":"8","author":"Taccone","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R49-6-20240828","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12250-020-00204-7","article-title":"Old weapon for new enemy: Drug repurposing for treatment of newly emerging viral diseases","volume":"35","author":"Guo","year":"2020","journal-title":"Virol Sin"},{"key":"R50-6-20240828","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment with lopinavir\/ritonavir or interferon-\u03b21b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset","volume":"212","author":"Chan","year":"2015","journal-title":"J Infect Dis"},{"key":"R51-6-20240828","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3851\/IMP3002","article-title":"Combination therapy with lopinavir\/ritonavir, ribavirin and interferon-\u03b1 for Middle East respiratory syndrome","volume":"21","author":"Kim","year":"2016","journal-title":"Antivir Ther"},{"key":"R52-6-20240828","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat Commun"},{"key":"R53-6-20240828","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"key":"R54-6-20240828","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/21645515.2020.1735227","article-title":"COVID-19, an emerging coronavirus infection: Advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics","volume":"16","author":"Dhama","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"R55-6-20240828","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11655-020-3192-6","article-title":"Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19).A review of historical classics, research evidence and current prevention programs?","volume":"26","author":"Luo","year":"2020","journal-title":"Chin J Integr Med"},{"key":"R56-6-20240828","first-page":"1","article-title":"Probiotics-identification and ways of action","volume":"6","author":"Corcionivoschi","year":"2010","journal-title":"Innov Rom Food Biotechnol"},{"key":"R57-6-20240828","first-page":"CD006895","article-title":"Probiotics for preventing acute upper respiratory tract infections","volume":"2","author":"Hao","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R58-6-20240828","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/gutjnl-2020-321195","article-title":"COVID-19 and the gastrointestinal tract: More than meets the eye","volume":"69","author":"Ng","year":"2020","journal-title":"Gut"},{"key":"R59-6-20240828","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(20)30113-4","article-title":"Viral load of SARSCoV-2 in clinical samples","volume":"20","author":"Pan","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R60-6-20240828","doi-asserted-by":"crossref","first-page":"e00614","DOI":"10.1128\/mSystems.00614-20","article-title":"SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases","volume":"5","author":"Wu","year":"2020","journal-title":"mSystems"},{"key":"R61-6-20240828","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/advances\/nmaa003","article-title":"Preventing respiratory tract infections by synbiotic interventions: A systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Chan","year":"2020","journal-title":"Adv Nutr"},{"key":"R62-6-20240828","doi-asserted-by":"crossref","first-page":"G315","DOI":"10.1152\/ajpgi.00265.2006","article-title":"The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells","volume":"292","author":"Caballero-Franco","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R63-6-20240828","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2180-9-63","article-title":"L.plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells","volume":"9","author":"Qin","year":"2009","journal-title":"BMC Microbiol"},{"key":"R64-6-20240828","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000496426","article-title":"Beneficial effects of probiotic consumption on the immune system","volume":"74","author":"Maldonado Galdeano","year":"2019","journal-title":"Ann Nutr Metab"},{"key":"R65-6-20240828","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1080\/10408398.2018.1490885","article-title":"Probiotics interaction with foodborne pathogens: A potential alternative to antibiotics and future challenges","volume":"59","author":"Wan","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"R66-6-20240828","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1007\/s00253-019-09978-7","article-title":"Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health","volume":"103","author":"Monteagudo-Mera","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"key":"R67-6-20240828","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(94)91708-6","article-title":"Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus","volume":"344","author":"Saavedra","year":"1994","journal-title":"Lancet"},{"key":"R68-6-20240828","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00203-017-1400-3","article-title":"Modulation of rotavirus severe gastroenteritis by the combination of probiotics and prebiotics","volume":"199","author":"Gonzalez-Ochoa","year":"2017","journal-title":"Arch Microbiol"},{"key":"R69-6-20240828","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1080\/15257770.2015.1125000","article-title":"Evaluation of purine utilization by Lactobacillus gasseri strains with potential to decrease the absorption of food-derived purines in the human intestine","volume":"35","author":"Yamada","year":"2016","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"R70-6-20240828","first-page":"25","article-title":"Reducing effect of Lactobacillus gasseri PA-3 on the absorption of food-derived purines","volume":"65","author":"Yamada","year":"2016","journal-title":"Milk Sci"},{"key":"R71-6-20240828","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/14397595.2018.1442183","article-title":"Hypouricaemic effects of yoghurt containing Lactobacillus gasseri PA-3 in patients with hyperuricaemia and\/or gout: A randomised, double-blind, placebo-controlled study","volume":"29","author":"Yamanaka","year":"2019","journal-title":"Mod Rheumatol"},{"key":"R72-6-20240828","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/gidisord1020022","article-title":"Bifidobacteria and mucosal-associated invariant T (MAIT) cells: A new approach to colorectal cancer prevention?","volume":"1","author":"Bozkurt","year":"2019","journal-title":"Gastrointest Disord"},{"key":"R73-6-20240828","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/jmv.25719","article-title":"COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis","volume":"92","author":"Angeletti","year":"2020","journal-title":"J Med Virol"},{"key":"R74-6-20240828","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.3168\/jds.2018-16103","article-title":"Lactobacillus plantarum DR7 improved upper respiratory tract infections via enhancing immune and inflammatory parameters: A randomized, double-blind, placebo-controlled study","volume":"102","author":"Chong","year":"2019","journal-title":"J Dairy Sci"},{"key":"R75-6-20240828","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.synbio.2018.03.001","article-title":"Prospective study of probiotic supplementation results in immune stimulation and improvement of upper respiratory infection rate","volume":"3","author":"Zhang","year":"2018","journal-title":"Synth Syst Biotechnol"},{"key":"R76-6-20240828","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3389\/fimmu.2017.00948","article-title":"Peptidoglycan from immunobiotic Lactobacillus rhamnosus improves resistance of infant mice to respiratory syncytial viral infection and secondary pneumococcal pneumonia","volume":"8","author":"Clua","year":"2017","journal-title":"Front Immunol"},{"key":"R77-6-20240828","doi-asserted-by":"crossref","first-page":"6764919","DOI":"10.1155\/2019\/6764919","article-title":"Interactions between intestinal microflora\/probiotics and the immune system","volume":"2019","author":"Zhang","year":"2019","journal-title":"Biomed Res Int"},{"key":"R78-6-20240828","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/nu3100858","article-title":"Regulation of inflammation by short chain fatty acids","volume":"3","author":"Vinolo","year":"2011","journal-title":"Nutrients"},{"key":"R79-6-20240828","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/nrmicro2690","article-title":"Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa","volume":"10","author":"Bron","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"R80-6-20240828","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/1574-6976.12021","article-title":"Genomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health","volume":"37","author":"Selle","year":"2013","journal-title":"FEMS Microbiol Rev"},{"key":"R81-6-20240828","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fcimb.2020.00009","article-title":"The gut-lung axis in health and respiratory diseases: A place for inter-organ and inter-kingdom crosstalks","volume":"10","author":"Enaud","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"R82-6-20240828","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.3389\/fimmu.2018.02640","article-title":"Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia","volume":"9","author":"Hanada","year":"2018","journal-title":"Front Immunol"},{"key":"R83-6-20240828","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1016\/j.celrep.2020.02.013","article-title":"Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production","volume":"30","author":"Sencio","year":"2020","journal-title":"Cell Rep"},{"key":"R84-6-20240828","doi-asserted-by":"crossref","first-page":"281","DOI":"10.23736\/S0026-4806.20.06570-2","article-title":"A possible probiotic (S.salivarius K12) approach to improve oral and lung microbiotas and raise defenses against SAR S-CoV-2","volume":"111","author":"Di Pierro","year":"2020","journal-title":"Minerva Med"},{"key":"R85-6-20240828","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.immuni.2012.04.011","article-title":"Commensal bacteria calibrate the activation threshold of innate antiviral immunity","volume":"37","author":"Abt","year":"2012","journal-title":"Immunity"},{"key":"R86-6-20240828","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3389\/fimmu.2016.00633","article-title":"Respiratory antiviral immunity and immunobiotics: Beneficial effects on inflammation-coagulation interaction during influenza virus infection","volume":"7","author":"Zelaya","year":"2016","journal-title":"Front Immunol"},{"key":"R87-6-20240828","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.clnu.2005.02.006","article-title":"Effect of Lactobacillus gasseri PA 16\/8, Bifidobacterium longum SP 07\/3, B.bifidum MF 20\/5 on common cold episodes: A double blind, randomized, controlled trial","volume":"24","author":"de Vrese","year":"2005","journal-title":"Clin Nutr"},{"key":"R88-6-20240828","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1271\/bbb.90749","article-title":"Effects of Bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the elderly","volume":"74","author":"Namba","year":"2010","journal-title":"Biosci Biotechnol Biochem"},{"key":"R89-6-20240828","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1097\/MCG.0b013e31817e1c91","article-title":"A new chance of preventing winter diseases by the administration of synbiotic formulations","volume":"42","author":"Pregliasco","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"R90-6-20240828","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1017\/S0007114509991395","article-title":"Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial","volume":"103","author":"Guillemard","year":"2010","journal-title":"Br J Nutr"},{"key":"R91-6-20240828","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/07315724.2010.10719882","article-title":"Effects of consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 on common respiratory and gastrointestinal infections in shift workers in a randomized controlled trial","volume":"29","author":"Guillemard","year":"2010","journal-title":"J Am Coll Nutr"},{"key":"R92-6-20240828","doi-asserted-by":"crossref","first-page":"e0166232","DOI":"10.1371\/journal.pone.0166232","article-title":"The clinical and economic impact of probiotics consumption on respiratory tract infections: Projections for Canada","volume":"11","author":"Lenoir-Wijnkoop","year":"2016","journal-title":"PLoS One"},{"key":"R93-6-20240828","first-page":"CD006095","article-title":"Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children","volume":"12","author":"Goldenberg","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R94-6-20240828","first-page":"CD004827","article-title":"Probiotics for the prevention of pediatric antibiotic-associated diarrhea","volume":"4","author":"Guo","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R95-6-20240828","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/apt.15267","article-title":"Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children-a 2019 update","volume":"49","author":"Szajewska","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R96-6-20240828","doi-asserted-by":"crossref","first-page":"e006474","DOI":"10.1136\/bmjopen-2014-006474","article-title":"Can probiotic yogurt prevent diarrhoea in children on antibiotics.A double-blind, randomised, placebo-controlled study?","volume":"5","author":"Fox","year":"2015","journal-title":"BMJ Open"},{"key":"R97-6-20240828","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1001\/jama.2012.3507","article-title":"Probiotics for the prevention and treatment of antibiotic-associated diarrhea: A systematic review and meta-analysis","volume":"307","author":"Hempel","year":"2012","journal-title":"JAMA"},{"key":"R98-6-20240828","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.nut.2014.11.013","article-title":"Yogurt for treating antibiotic-associated diarrhea: Systematic review and meta-analysis","volume":"31","author":"Patro-Golab","year":"2015","journal-title":"Nutrition"},{"key":"R99-6-20240828","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/apt.13404","article-title":"Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults","volume":"42","author":"Szajewska","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R100-6-20240828","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/0884533616639399","article-title":"Probiotics reduce the risk of antibiotic-associated diarrhea in adults (18-64 years) but not the elderly (>65 years): A meta-analysis","volume":"31","author":"Jafarnejad","year":"2016","journal-title":"Nutr Clin Pract"},{"key":"R101-6-20240828","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2013.08.020","article-title":"Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: A randomized, placebo-controlled trial","volume":"133","author":"Luoto","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"R102-6-20240828","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/jmv.23623","article-title":"The use of the probiotic Lactobacillus rhamnosus GG and viral findings in the nasopharynx of children attending day care","volume":"85","author":"Kumpu","year":"2013","journal-title":"J Med Virol"},{"key":"R103-6-20240828","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/lam.12340","article-title":"Effects of probiotic Lactobacillus brevis KB 290 on incidence of influenza infection among school children: An open-label pilot study","volume":"59","author":"Waki","year":"2014","journal-title":"Lett Appl Microbiol"},{"key":"R104-6-20240828","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature23480","article-title":"A randomized synbiotic trial to prevent sepsis among infants in rural India","volume":"548","author":"Panigrahi","year":"2017","journal-title":"Nature"},{"key":"R105-6-20240828","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1017\/S0007114508116282","article-title":"Specific probiotics in reducing the risk of acute infections in infancy \u2013 a randomised, double-blind, placebo-controlled study","volume":"101","author":"Rautava","year":"2009","journal-title":"Br J Nutr"},{"key":"R106-6-20240828","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nut.2007.01.004","article-title":"Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination","volume":"23","author":"Olivares","year":"2007","journal-title":"Nutrition"},{"key":"R107-6-20240828","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3920\/BM2016.0160","article-title":"Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection-a randomised controlled trial","volume":"8","author":"Turner","year":"2017","journal-title":"Benef Microbes"},{"key":"R108-6-20240828","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-065X.2011.01073.x","article-title":"Control of antiviral immunity by pattern recognition and the microbiome","volume":"245","author":"Pang","year":"2012","journal-title":"Immunol Rev"},{"key":"R109-6-20240828","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/jgs.15396","article-title":"Probiotics to prevent respiratory infections in nursing homes: A pilot randomized controlled trial","volume":"66","author":"Wang","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"R110-6-20240828","doi-asserted-by":"crossref","first-page":"8129","DOI":"10.1039\/C9FO02128K","article-title":"The effects of OLL1073R-1 yogurt intake on influenza incidence and immunological markers among women healthcare workers: A randomized controlled trial","volume":"10","author":"Kinoshita","year":"2019","journal-title":"Food Funct"},{"key":"R111-6-20240828","first-page":"CD009066","article-title":"Probiotics for preventing ventilator-associated pneumonia","volume":"10","author":"Bo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R112-6-20240828","doi-asserted-by":"crossref","first-page":"e0151976","DOI":"10.1371\/journal.pone.0151976","article-title":"The effect of probiotic treatment on patients infected with the H7N9 influenza virus","volume":"11","author":"Hu","year":"2016","journal-title":"PLoS One"},{"key":"R113-6-20240828","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4014\/jmb.1909.09041","article-title":"Surface-displayed porcine IFN-\u03bb3 in Lactobacillus plantarum inhibits porcine enteric coronavirus infection of porcine intestinal epithelial cells","volume":"30","author":"Liu","year":"2020","journal-title":"J Microbiol Biotechnol"},{"key":"R114-6-20240828","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.omtm.2019.06.007","article-title":"Expression of human ACE2 in Lactobacillus and beneficial effects in diabetic retinopathy in mice","volume":"14","author":"Verma","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R115-6-20240828","first-page":"1","article-title":"Probiotics in the prophylaxis of COVID-19: Something is better than nothing","volume":"11","author":"Gohil","year":"2021","journal-title":"3 Bitech"},{"key":"R116-6-20240828","doi-asserted-by":"crossref","first-page":"100837","DOI":"10.1016\/j.nmni.2021.100837","article-title":"Oral probiotics in coronavirus disease 2019: Connecting the gut-lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials","volume":"40","author":"Baindara","year":"2021","journal-title":"New Microbes New Infect"},{"key":"R117-6-20240828","doi-asserted-by":"crossref","first-page":"m606","DOI":"10.1136\/bmj.m606","article-title":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series","volume":"368","author":"Xu","year":"2020","journal-title":"BMJ"},{"key":"R118-6-20240828","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fpubh.2020.00186","article-title":"Using probiotics to flatten the curve of coronavirus disease COVID-2019 pandemic","volume":"8","author":"Baud","year":"2020","journal-title":"Front Public Health"},{"key":"R119-6-20240828","first-page":"1","article-title":"The volatile and heterogenous gut microbiota shifts of COVID-19 patients over the course of a probiotics-assisted therapy","volume":"1","author":"Wu","year":"2021","journal-title":"Res Square"},{"key":"R121-6-20240828","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fmed.2020.00389","article-title":"Challenges in the management of SARS-CoV2 infection: The role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19","volume":"7","author":"d'Ettorre","year":"2020","journal-title":"Front Med (Lausanne"},{"key":"R124-6-20240828","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/CMR.00077-12","article-title":"Human rhinoviruses","volume":"26","author":"Jacobs","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"R125-6-20240828","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/gut.2008.167270","article-title":"The efficacy of probiotics in the treat-ment of irritable bowel syndrome: A systematic review","volume":"59","author":"Moayyedi","year":"2010","journal-title":"Gut"},{"key":"R126-6-20240828","doi-asserted-by":"crossref","first-page":"e34938","DOI":"10.1371\/journal.pone.0034938","article-title":"A meta-analysis of probiotic efficacy for gastrointestinal diseases","volume":"7","author":"Ritchie","year":"2012","journal-title":"PLoS One"},{"key":"R127-6-20240828","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/jmf.2013.3083","article-title":"Health benefits of kimchi (Korean fermented vegetables) as a probiotic food","volume":"17","author":"Park","year":"2014","journal-title":"J Med Food"},{"key":"R128-6-20240828","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1399-6576.2008.01748.x","article-title":"Lactobacillus plantarum 299 v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics","volume":"52","author":"Klarin","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"key":"R129-6-20240828","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13054-018-2167-x","article-title":"Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: A randomized controlled trial","volume":"22","author":"Shimizu","year":"2018","journal-title":"Crit Care"},{"key":"R130-6-20240828","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3920\/BM2014.0164","article-title":"Effect of live and inactivated Lactobacillus rhamnosus GG on experimentally induced rhinovirus colds: Randomised, double blind, placebo-controlled pilot trial","volume":"6","author":"Kumpu","year":"2015","journal-title":"Benef Microbes"},{"key":"R131-6-20240828","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/07315724.2014.983249","article-title":"Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 ingestion induces a less inflammatory cytokine profile and a potentially beneficial shift in gut microbiota in older adults: A randomized, double-blind, placebo-controlled, crossover study","volume":"34","author":"Spaiser","year":"2015","journal-title":"J Am Coll Nutr"},{"key":"R132-6-20240828","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13054-016-1434-y","article-title":"Probiotic and symbiotic therapy in critical illness: A systematic review and meta-analysis","volume":"19","author":"Manzanares","year":"2016","journal-title":"Crit Care"},{"key":"R133-6-20240828","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s001340050367","article-title":"Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients.A multicenter, randomized, double-blind placebo-controlled trial","volume":"23","author":"Bleichner","year":"1997","journal-title":"Intensive Care Med"},{"key":"R134-6-20240828","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00007890-200207150-00021","article-title":"Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: A controlled trial in liver transplant recipients","volume":"74","author":"Rayes","year":"2002","journal-title":"Transplantation"},{"key":"R135-6-20240828","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/cc6907","article-title":"Oral probiotic and prevention of Pseudomonas aeruginosa infections: A randomized, double-blind, placebo-controlled pilot study in intensive care unit patients","volume":"12","author":"Forestier","year":"2008","journal-title":"Crit Care"},{"key":"R136-6-20240828","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/apt.13344","article-title":"Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea","volume":"42","author":"Szajewska","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R137-6-20240828","first-page":"CD003048","article-title":"Probiotics for treating acute infectious diarrheae","volume":"2010","author":"Allen","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R138-6-20240828","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/0148607112467819","article-title":"Clinical effects of probiotic Bifidobacterium longum BB536 on immune function and intestinal microbiota in elderly patients receiving enteral tube feeding","volume":"37","author":"Akatsu","year":"2013","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R139-6-20240828","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00394-010-0127-6","article-title":"Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections","volume":"50","author":"Berggren","year":"2011","journal-title":"Eur J Nutr"},{"key":"R140-6-20240828","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1017\/S0007114512004138","article-title":"Effect of Lactobacillus rhamnosus LGG\u00ae and Bifidobacterium animalis ssp.lactis BB-12\u00ae on health-related quality of life in college students affected by upper respiratory infections","volume":"109","author":"Smith","year":"2013","journal-title":"Br J Nutr"},{"key":"R141-6-20240828","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/alr.21748","article-title":"Human rhinovirus in experimental infection after peroral Lactobacillus rhamnosus GG consumption, a pilot study","volume":"6","author":"Tapiovaara","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"R142-6-20240828","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jmii.2014.07.011","article-title":"Oral intake of Lactobacillus rhamnosus M21 enhances the survival rate of mice lethally infected with influenza virus","volume":"49","author":"Song","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"R143-6-20240828","doi-asserted-by":"crossref","first-page":"6670e4","DOI":"10.1016\/j.vaccine.2006.05.048","article-title":"Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial","volume":"24","author":"de Vrese","year":"2006","journal-title":"Vaccine"},{"key":"R144-6-20240828","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/CS20030251","article-title":"Benefits of early enteral nutrition with glutamine and probiotics in brain injury patients","volume":"106","author":"Falc\u00e3o de Arruda","year":"2004","journal-title":"Clin Sci (Lond"},{"key":"R145-6-20240828","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2036.2007.03362.x","article-title":"Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: A multicentre, randomized, double-blind, controlled trial","volume":"26","author":"Guyonnet","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R146-6-20240828","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1017\/S0007114509990882","article-title":"Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: A randomised, double-blind, parallel, controlled study","volume":"102","author":"Guyonnet","year":"2009","journal-title":"Br J Nutr"},{"key":"R147-6-20240828","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/bmj.322.7298.1327","article-title":"Effect of long term consumption of probiotic milk on infections in children attending day care centres: Double blind, randomised trial","volume":"322","author":"Hatakka","year":"2001","journal-title":"BMJ"},{"key":"R148-6-20240828","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1016\/j.vaccine.2009.06.094","article-title":"A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials","volume":"27","author":"Boge","year":"2009","journal-title":"Vaccine"},{"key":"R149-6-20240828","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1007\/s00268-005-0653-1","article-title":"Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: Early results of a randomized controlled trial","volume":"30","author":"Kotzampassi","year":"2006","journal-title":"World J Surg"}],"container-title":["Tzu Chi Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_104_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:06:56Z","timestamp":1787166416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_104_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":140,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/tcmj.tcmj_104_21","relation":{},"ISSN":["1016-3190"],"issn-type":[{"value":"1016-3190","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}